These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 29188558)

  • 1. Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design.
    Ciancetta A; Jacobson KA
    Methods Mol Biol; 2018; 1705():45-72. PubMed ID: 29188558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. John Daly Lecture: Structure-guided Drug Design for Adenosine and P2Y Receptors.
    Jacobson KA; Gao ZG; Paoletta S; Kiselev E; Chakraborty S; Jayasekara PS; Balasubramanian R; Tosh DK
    Comput Struct Biotechnol J; 2015; 13():286-98. PubMed ID: 25973142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico Drug Design for Purinergic GPCRs: Overview on Molecular Dynamics Applied to Adenosine and P2Y Receptors.
    Salmaso V; Jacobson KA
    Biomolecules; 2020 May; 10(6):. PubMed ID: 32466404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates.
    Jacobson KA
    J Med Chem; 2013 May; 56(10):3749-67. PubMed ID: 23597047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPCR crystal structures: Medicinal chemistry in the pocket.
    Shonberg J; Kling RC; Gmeiner P; Löber S
    Bioorg Med Chem; 2015 Jul; 23(14):3880-906. PubMed ID: 25638496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
    Bermudez M; Wolber G
    Bioorg Med Chem; 2015 Jul; 23(14):3907-12. PubMed ID: 25828056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligands.
    Trujillo K; Paoletta S; Kiselev E; Jacobson KA
    Bioorg Med Chem; 2015 Jul; 23(14):4056-64. PubMed ID: 25868749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and Future Challenges in GPCR Drug Discovery.
    Topiol S
    Methods Mol Biol; 2018; 1705():1-21. PubMed ID: 29188556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Ligand Binding to GPCRs Through Computational Methods.
    Vasile S; Esguerra M; Jespers W; Oliveira A; Sallander J; Åqvist J; Gutiérrez-de-Terán H
    Methods Mol Biol; 2018; 1705():23-44. PubMed ID: 29188557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicinal chemistry of adenosine, P2Y and P2X receptors.
    Jacobson KA; Müller CE
    Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular docking screening using agonist-bound GPCR structures: probing the A2A adenosine receptor.
    Rodríguez D; Gao ZG; Moss SM; Jacobson KA; Carlsson J
    J Chem Inf Model; 2015 Mar; 55(3):550-63. PubMed ID: 25625646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design.
    Cong X; Topin J; Golebiowski J
    Curr Pharm Des; 2017 Nov; 23(29):4390-4409. PubMed ID: 28699533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T; Simms J; Christopoulos A; Wootten D; Sexton PM
    PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic Signaling: Impact of GPCR Structures on Rational Drug Design.
    Salmaso V; Jacobson KA
    ChemMedChem; 2020 Nov; 15(21):1958-1973. PubMed ID: 32803849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-based homology modeling as attractive tool to inspect GPCR structural plasticity.
    Moro S; Deflorian F; Bacilieri M; Spalluto G
    Curr Pharm Des; 2006; 12(17):2175-85. PubMed ID: 16796562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated In Silico Fragment-Based Drug Design: Case Study with Allosteric Modulators on Metabotropic Glutamate Receptor 5.
    Bian Y; Feng Z; Yang P; Xie XQ
    AAPS J; 2017 Jul; 19(4):1235-1248. PubMed ID: 28560482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
    Bartuzi D; Kaczor AA; Matosiuk D
    Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptors.
    Jacobson KA; Costanzi S
    Mol Pharmacol; 2012 Sep; 82(3):361-71. PubMed ID: 22695719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress on the discovery of P2Y
    Lu R; Zhang Z; Jiang C
    Eur J Med Chem; 2019 Aug; 175():34-39. PubMed ID: 31071548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
    Lu S; Zhang J
    J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.